Cannabistry Labs and Thar Process Join Forces to Exclusively Launch Pharma Grade Supercritical Extraction Technology to the Cannabis Industry
CHICAGO, Dec. 11, 2018 /PRNewswire/ -- Cannabistry Labs(®), a leader in scientific research and product development in the cannabis industry, today announced a newly formed partnership with the global innovator in supercritical fluid technology and equipment, Thar Process, to make cutting-edge, pharmaceutical grade carbon dioxide (CO(2)) extraction technology available to the cannabis industry for the first time.
"For over thirty years, Thar Process has been the pharmaceutical and flavor industries' leader in developing best-in-class supercritical fluid technology and equipment," said Scott Mandell, President of Cannabistry Labs. "When you combine their expertise with our team's five years of rigorous lab work and product development creating new cannabis technologies and production methods, both of our companies saw the opportunity to significantly raise the bar over existing cannabis extraction technology."
The companies have executed a multi-year exclusive supply agreement, based on the development of proprietary CO(2) extraction equipment, to be offered only to Cannabistry Labs' and its domestic and international partners. The first extraction system created for the partnership, the CL-24, is specifically designed to optimize Cannabistry Labs' proprietary Hi-Phi(TM) extraction technology, which is uniquely capable of producing extracts whose compounds are nature-identical to the native plant. Thar Process and Cannabistry Labs worked together to optimize high-efficiency extraction output while retaining all of Hi-Phi technology's distinct qualitative advantages.
"When you meet the Cannabistry Labs scientific team, see their facilities and become familiar with their work, it's easy to see how our companies' collective experience and know-how can be leveraged," said Todd Palcic, President of Thar Process. "There is a reason that despite Thar's proven track record in CO(2) extraction, we waited until now to enter the cannabis space."
The new partnership's supercritical technology will be offered and deployed throughout facilities across the nation soon.
About Cannabistry Labs
Cannabistry Labs is a pioneer in developing and licensing innovative products and revolutionary brands for the multi-billion-dollar legalized cannabis industry. Its team of scientists, engineers and production specialists work collaboratively to research, develop and formulate a diverse array of product offerings. Through an exclusive licensing program, Cannabistry Labs helps empower partners' operations to produce and market demonstrably better products and uniquely compelling brands.
To learn more about Cannabistry Labs, please visit www.cannabistry.com
About Thar Process
Thar Process, Inc. is the global innovation leader in supercritical CO2 technology from toll processing to turn-key equipment solutions. From CO2 extraction (SFE) to CO2 Counter-Current Purification (CCC) to CO2 Chromatography (SFC) - Thar designs equipment at the nexus of process development and optimization. Over nearly three decades, Thar has provided equipment and services to the pharmaceutical, food, supplements, chemical and medical device industries in 6 continents. With our proprietary technology, R&D and processing services complementing our expertise in production-scale equipment, Thar Process is the only single-point-of-access provider of supercritical fluid technology solutions worldwide.
To learn more about Thar Process, please visit http://tharprocess.com/
Media Contact:
Hannah May
614-218-6022
Hannah@hercreativemedia.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/cannabistry-labs-and-thar-process-join-forces-to-exclusively-launch-pharma-grade-supercritical-extraction-technology-to-the-cannabis-industry-300762873.html
SOURCE Cannabistry Labs
